<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">34125573</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>11</Month>
        <Day>02</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>11</Month>
        <Day>02</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1539-3704</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>174</Volume>
            <Issue>10</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>Oct</Month>
            </PubDate>
          </JournalIssue>
          <Title>Annals of internal medicine</Title>
          <ISOAbbreviation>Ann Intern Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Severe Exacerbations of Systemic Capillary Leak Syndrome After COVID-19 Vaccination: A Case Series.</ArticleTitle>
        <Pagination>
          <StartPage>1476</StartPage>
          <EndPage>1478</EndPage>
          <MedlinePgn>1476-1478</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">L21-0250</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.7326/L21-0250</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Matheny</LastName>
            <ForeName>Meghan</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">0000-0003-3981-520X</Identifier>
            <AffiliationInfo>
              <Affiliation>National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Maleque</LastName>
            <ForeName>Noble</ForeName>
            <Initials>N</Initials>
            <Identifier Source="ORCID">0000-0002-9829-4662</Identifier>
            <AffiliationInfo>
              <Affiliation>Emory University School of Medicine and Rollins School of Public Health, Atlanta, Georgia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Channell</LastName>
            <ForeName>Natalie</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Maine Medical Center, Portland, Maine.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Eisch</LastName>
            <ForeName>A Robin</ForeName>
            <Initials>AR</Initials>
            <AffiliationInfo>
              <Affiliation>National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Auld</LastName>
            <ForeName>Sara C</ForeName>
            <Initials>SC</Initials>
            <Identifier Source="ORCID">0000-0002-8972-3736</Identifier>
            <AffiliationInfo>
              <Affiliation>Emory University School of Medicine and Rollins School of Public Health, Atlanta, Georgia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Banerji</LastName>
            <ForeName>Aleena</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Druey</LastName>
            <ForeName>Kirk M</ForeName>
            <Initials>KM</Initials>
            <Identifier Source="ORCID">0000-0002-5834-6501</Identifier>
            <AffiliationInfo>
              <Affiliation>National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>ZIA AI001083</GrantID>
            <Acronym>ImNIH</Acronym>
            <Agency>Intramural NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>06</Month>
          <Day>15</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Ann Intern Med</MedlineTA>
        <NlmUniqueID>0372351</NlmUniqueID>
        <ISSNLinking>0003-4819</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D002317">Cardiovascular Agents</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D016756">Immunoglobulins, Intravenous</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>C137DTR5RG</RegistryNumber>
          <NameOfSubstance UI="D013806">Theophylline</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>N8ONU3L3PG</RegistryNumber>
          <NameOfSubstance UI="D013726">Terbutaline</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
          <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019559" MajorTopicYN="N">Capillary Leak Syndrome</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002317" MajorTopicYN="N">Cardiovascular Agents</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016756" MajorTopicYN="N">Immunoglobulins, Intravenous</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013726" MajorTopicYN="N">Terbutaline</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013806" MajorTopicYN="N">Theophylline</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <CoiStatement>
<b>Disclosures:</b> Authors have reported no disclosures of interest. Forms can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=L21-0250.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>6</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>3</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>6</Month>
          <Day>14</Day>
          <Hour>17</Hour>
          <Minute>13</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34125573</ArticleId>
        <ArticleId IdType="pmc">PMC8252024</ArticleId>
        <ArticleId IdType="doi">10.7326/L21-0250</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>

Eo TS
, 
Chun KJ
, 
Hong SJ
, et al. Clinical presentation, management, and prognostic factors of idiopathic systemic capillary leak syndrome: a systematic review. J Allergy Clin Immunol Pract. 2018;6:609-618. [PMID: ] doi:10.1016/j.jaip.2017.07.021
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jaip.2017.07.021</ArticleId>
            <ArticleId IdType="pubmed">28939140</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Pineton de Chambrun M, Luyt CE, Beloncle F, et al; EurêClark Study Group.. The clinical picture of severe systemic capillary-leak syndrome episodes requiring ICU admission. Crit Care Med. 2017;45:1216-1223. [PMID: ] doi:10.1097/CCM.0000000000002496
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/CCM.0000000000002496</ArticleId>
            <ArticleId IdType="pubmed">28622216</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Pineton de Chambrun M, Gousseff M, Mauhin W, et al; EurêClark Study Group.. Intravenous immunoglobulins improve survival in monoclonal gammopathy-associated systemic capillary-leak syndrome. Am J Med. 2017;130:1219.e19-1219.e27. [PMID: ] doi:10.1016/j.amjmed.2017.05.023
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.amjmed.2017.05.023</ArticleId>
            <ArticleId IdType="pubmed">28602874</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Druey KM
, 
Parikh SM
. Idiopathic systemic capillary leak syndrome (Clarkson disease). J Allergy Clin Immunol. 2017;140:663-670. [PMID: ] doi:10.1016/j.jaci.2016.10.042
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jaci.2016.10.042</ArticleId>
            <ArticleId IdType="pmc">PMC5481509</ArticleId>
            <ArticleId IdType="pubmed">28012935</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Pineton de Chambrun M, Cohen-Aubart F, Donker DW, et al.. SARS-CoV-2 induces acute and refractory relapse of systemic capillary leak syndrome (Clarkson's disease). Am J Med. 2020;133:e663-e664. [PMID: ] doi:10.1016/j.amjmed.2020.03.057
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.amjmed.2020.03.057</ArticleId>
            <ArticleId IdType="pmc">PMC7217792</ArticleId>
            <ArticleId IdType="pubmed">32405072</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
